CPSC recall 26157 · Dec 18, 2025
Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Product
Mamisan Pain Relieving Topical Ointment
Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
What to do
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Recall details
- Description
- This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
- Units
- About 50,330
- Incidents and injuries
- None reported
- Sold at
- Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
- Company
- MiramarLab, of Doral, Florida
- Manufactured in
- United States
- Consumer contact
- Plantimex toll-free at 855-752-6869 from 9 a.m. to 4 p.m. PT Monday through Friday, email at [email protected] with the subject "RECALL" or online at http://plantimexusa.com/contact.php or www.plantimexusa.com and contact us for more information.
Source: U.S. Consumer Product Safety Commission (CPSC) notice.
Copied from the agency record without changes. Data as of Oct 14, 2026, 1:15 AM EDT. The agency notice is the final word.
Check something else